Guangdong Province Hospital of Tradtional Chinese Medicine
Guangzhou, Guangdong, 510120, China
Location status: Recruiting
NCT Number: NCT05315895
The researchers plain to build a large-scale, longitudinal, prospective cohort characterized by TCM dampness syndrome. With the biobank of this cohort the investigators want to find the causality between TCM dampness syndrome and clinical chronic diseases and a new way to treat clinical disease.
Interested in participating?
Request Info35 year–79 year
All sexes
Observational
Guangzhou, Guangdong, 510120, China
Location status: Recruiting
DACOS is a national large- scale, longitudinal, multi-center, prospective, cohort study of natural person aged 35 to 75. The baseline survey and the follow-up surveys will be conducted in 5 areas covering the eastern, northern, western, southern and middle parts of China. In this study 100,000 natural person will be regularly followed up for 5 years(visited once a year), with the loss rate ≤15%. Three parts will be carried in the form of interview, physical examination and biological sample collection. During the interview, the investigators plan to do some questionnaires to learn participants' demographic characteristics, life style, disease history, healthy condition(EQ-5D-5L, SDS,), cognition state(AD-8, MMSE, MoCA) and the results of TCM syndrome differentiation(Score of Dampness syndrome and TCM constitution scale). All biological specimens (including blood, feces, urine, saliva and tongue coating) will be collected and stored in the biological resource center until researchers request their use. With the building up of this cohort, the researchers will analyze the causality between dampness syndrome and specific chronic diseases such as diabetes, coronary heart disease, cancer, dementia and so on.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
To observe the relationship between new cases of diseases and health status of people exposed to different factors such as life style, alcohol consumption, eating habits, etc.
Time frame: through study completion, an average of 1 year
This study will pay attention to the emerging situation of clinical chronic diseases, such as cancer, diabetes, hypertension, coronary heart disease, dementia, etc. Each follow-up the researchers will record the incidence of the emerging diseases of interviewees' by questionnaire including the name of the disease, time of onset and treatments.
Time frame: through study completion, an average of 1 year
MoCA is a brief, 30-question test that helps healthcare professionals detect cognitive impairments very early on, allowing for faster diagnosis and patient care. MoCA is the most sensitive test available for detecting Alzheimer's disease, measuring executive functions and multiple cognitive domains. The value range 0-30: higher scores mean a better Cognitine. The score above 26 is considered the normal congnitive level
Time frame: through study completion, an average of 1 year
The EQ-5D comprises five dimensions of health: mobility, ability to self-care, ability to undertake usual activities, pain and discomfort, and anxiety and depression. . EQ-5D-5L, includes five levels of severity for each dimension (no problems, slight problems, moderate problems, severe problems, and extreme problems). The value range 0-100: higher scores mean a worse outcome.
Time frame: through study completion, an average of 1 year
MMSE is a widely used test of cognitive function among the elderly; it includes tests of orientation, attention, memory, language and visual-spatial skills. The value range 0-30: higher scores mean a better Cognitine.
Time frame: through study completion, an average of 1 year
Demographic characteristic, life style. disease history, allergies will be involoved.
Time frame: through study completion, an average of 1 year
WBC, RBC, PLT , HB, NEUT% and LYM% will be tested and recorded. Above or below each mormal value will be considered as abnormal.
Time frame: through study completion, an average of 1 year
urinary WBC and urinary RBC will be observed. negative or below 5/HP is normal.
BLO and GLU and PRO in urine will also be test. Negative is normal.
Time frame: through study completion, an average of 1 year
cells in faeces will be tested such as RBC and WBC. Negative occult blood(FOB) is difined normal.
Time frame: an average of 1 year
The researchers will check the results of ALT and AST. TBil, DBIL, TBA and TP, ALB. Any indices above or below the criteria range is defined as abnormal. Every time point investigators will record the change of these indices.
Time frame: an average of 1 year
The researchers will check the results of Cr, BUN, TC, LDL, HDL,UA and fasting blood glucose,glycosylanted. Any indices above or below the criteria range is defined as abnormal. Every time point investigators will record the change of these indices.
Time frame: an average of 1 year
change of CPP
Time frame: an average of 1 year
change of Hcy
Time frame: an average of 1 year
change of TSH ,FT3, FT4
Time frame: an average of 1 year
change of Vit B12
Time frame: an average of 1 year
change of PT, INR,TT,APTT,FIB
Time frame: an average of 1 year
change of abdominal ultrasound
Time frame: an average of 1 year
change of gynecologic ultrasound
Time frame: an average of 1 year
The researchers will check the change of P, QRS and ST segments separately in electrocardiogram.
Time frame: an average of 1 year
change of brain MRI. The investigators will focus on the change of hippocampal volume and the spacing of temporal sulcus gyrus.
Contact information is provided by the study sponsor or research team.
Bin Zhang, PhD
CONTACT
Jianwen Guo, MD
CONTACT
Guangzhou University of Traditional Chinese Medicine
Other
A Multi-Center Prospective Cohort Study of Dampness Syndrome in China
Acronym: DACOS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03430141
Cancer, Cardiovascular Diseases
Flagstaff, Arizona, United States
View Trial DetailsNCT07391046
Asplenia, Autoimmune Diseases
View Trial DetailsNCT04037436
Arthritis, Bone Diseases
Cambridge, Ontario, Canada
View Trial DetailsNCT05739305
Cancer, Chronic Disease
Villavicencio, Meta Department, Colombia
View Trial Details